Clinical Advances in Hematology and Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q4 | 25.2% | 0.283 | Q3 | 41.4% |
| 2024 | — | — | 0.261 | Q3 | 40.8% | |
| 2023 | 1.1 | Q4 | 13.9% | 0.264 | Q3 | 44.8% |
| 2022 | 1.0 | 13.1% | 0.337 | Q3 | 54.2% | |
| 2021 | — | 25.2% | 0.323 | Q3 | 53.6% | |
| 2020 | — | — | 0.414 | Q3 | 60.5% | |
| 2019 | — | — | 0.462 | Q2 | 65.2% | |
| 2018 | — | — | 0.588 | Q2 | 70.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1543-0790
country
UScoverage
2003-2026